. "Drug combinations which contain tiotropium bromide as an additional active substance as well as the compounds of formula 1 according to the invention are particularly preferred according to the invention. [0071] This combination is particularly important in the treatment of asthma or COPD, particularly COPD. [0072] Suitable preparations for administering the compounds of formula 1 include, for exa" . . .